316L stainless steel is the standard material for pharmaceutical-grade supercritical extraction equipment. Nevertheless, there is a critical oversight in the industry: simply adopting 316L stainless steel does not guarantee compliance with USP standards.
The United States Pharmacopeia (USP) imposes strict limits on metal ion leachables from equipment product-contact surfaces, with particular emphasis on iron ion precipitation. The corrosion resistance of stainless steel derives from a nanoscale chromium oxide (Cr₂O₃) passive film on its surface, which locks internal iron elements and prevents them from migrating into finished products.
The key problem is that a mill test report verifying compliant 316L chemical composition cannot guarantee that finished equipment will pass the USP iron leaching test.
We have encountered this issue repeatedly in actual projects. Clients often obtain third-party test reports for equipment fittings that fully comply with ASTM chemical composition standards with qualified iron content. However, after on-site installation and USP validation testing, 24-hour purified water circulation tests show excessive iron leaching levels.
The root cause of this problem lies in unqualified pickling and passivation treatment.
Newly processed stainless steel surfaces have oxide scales and manufacturing contaminants. Welding and fabrication processes will further damage the original passive film. Professional pickling and passivation is required to selectively remove free surface iron, enrich surface chromium content, and form a dense and stable passive protective film. Many on-site construction teams only apply passivation paste briefly and rinse it hastily, with insufficient reaction time, inappropriate reagent concentration and uncontrolled processing temperature, resulting in incomplete and ineffective passive film formation.
We have established a standardized passivation process for all client projects: citric acid passivation at a constant temperature of 50–60°C for no less than 30 minutes, followed by thorough rinsing with purified water, and final blue-dot testing to verify passivation quality. The blue-dot test can effectively detect free iron ions on the material surface; blue spots indicate residual free iron and failed passivation treatment.
USP compliance is never solely dependent on the stainless steel alloy itself. Material quality is the foundation, and standardized passivation treatment is the core safeguard. Both are indispensable for meeting pharmaceutical-grade standards.